🟢 92/100

This product looks safe

  • Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • 80% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)

Label Data

1 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
80% Evidence Coverage

Supplement Facts — Evidence Check

50 mg (250% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 50mg UL 35mg
20 mg (1000% DV)
📊 15.4× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 20mg UL 100mg
1000 IU (250% DV)
✅ 1.7× RDA — within safe limits 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.025mg UL 0.1mg
0.2 mg (3333.34% DV)
📊 83.3× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.2mg
Anti-Aging Proprietary Blend
1430 mg

Other Ingredients

Gelatin Magnesium Stearate Rice Flour Titanium Dioxide FD&C Red #40 FD&CRed#3 FD&C Blue#1

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult Female (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take one (1) capsule with breakfast followed by one (1) capsule in the evening.

⚠️ Warnings & Precautions

Contains black cohosh which is not to be used while pregnant or nursing.

WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS.

It you are taking anti-depressants, birth control pills or other medications, consult with your healthcare professional before using this product.

WARNING: NEVER EXCEED RECOMMENDED DOSAGE

Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms.

KEEP OUT OF REACH OF CHILDREN. Not for use by persons under age 18.

Do not use if pregnant or nursing.

Do not exceed recommended dose.

Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

Do not use for more than 8 weeks.

Consult your physician prior to use if you are taking medication, including but not limited to, MAOI inhibitors, antidepressants, aspirin, non-steroidal antiinflammatory drugs or products containing phenylephrine, ephedrine, pseudo ephedrine, or other stimulants.

DO NOT USE IF PREGNANT OR NURSING or allergic or contraindicated to aspirin.

DO NOT USE IF PREGNANT OR NURSING or allergic or contraindicated to aspirin.

If you are taking aspirin or blood thinning or other medication, consult your physician before using this product.

Discontinue use two weeks prior to surgery or if stomach upset occurs.

Use of this product may cause your skin to be extra sensitive to UV sources, such as artificial or natural sunlight. Avoid excessive exposures from these sources.

Consult a physician or licensed qualified health care professional before using this product, including, but not limited to, if you have, or have a family history of, prostate cancer, prostate enlargement, heart disease, low "good" cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the- counter drug.

Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney, or thyroid disease, psychiatric disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heart beat, dizziness, severe headaches or shortness of breath

🧪 Formulation Notes

Contains black cohosh which is not to be used while pregnant or nursing.

Additional Information

MADE IN THE USA

INSPECTED GOOD MANUFACTURING PRACTICES cGMP FACILITY

To report any adverse event call 1-800-332-1088.

Product Details

UPC / SKU 8 11207 02158 9
DSLD Entry Date 2014-04-25
Product Type Other Combinations
Form Capsule
Brand Shredz
DSLD ID 31971
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →